BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20675885)

  • 1. [Thyroid-associated ophthalmopathy: case report of a euthyroid patient].
    Kabasawa C; Maruyama K; Kobayashi M; Shimizu Y; Iwata M; Uchiyama S
    Brain Nerve; 2010 Jul; 62(7):804-5. PubMed ID: 20675885
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid-associated inferior oblique myopathy.
    Kakizaki H; Zako M; Iwaki M
    Ophthalmology; 2007 Nov; 114(11):2106. PubMed ID: 17980760
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiotherapy-associated euthyroid Graves ophthalmopathy following floor-of-mouth surgery: a case report.
    Jaber JJ; Thomas FJ; Carfrae MJ; Galati LT
    Ear Nose Throat J; 2008 Sep; 87(9):533-6. PubMed ID: 18800329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Shih SR; Li HY; Hsiao YL; Chang TC
    Acta Ophthalmol; 2010 Aug; 88(5):e154-9. PubMed ID: 20553230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of thyroid ophthalmopathy--a clinical case].
    Andrei S; Zemba M; Zugravu V; Enache V; Renetti A; Spiroiu C
    Oftalmologia; 2007; 51(1):49-55. PubMed ID: 17605272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of digital infrared thermal imaging in determining inflammatory state and follow-up effect of methylprednisolone pulse therapy in patients with Graves' ophthalmopathy.
    Chang TC; Hsiao YL; Liao SL
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):45-9. PubMed ID: 17653750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.
    Lacka K; Manuszewska E; Korczowska I; Lacki JK
    Curr Eye Res; 2007 Mar; 32(3):291-7. PubMed ID: 17453949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
    Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
    Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital inflammatory disease.
    Danesh-Meyer HV; Rosser PM
    Int Ophthalmol Clin; 2007; 47(4):79-92, ix. PubMed ID: 18049282
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenal reserve following treatment of Graves' orbitopathy with intravenous glucocorticoids.
    Giotaki Z; Fountas A; Tsirouki T; Bargiota A; Tigas S; Tsatsoulis A
    Thyroid; 2015 Apr; 25(4):462-3. PubMed ID: 25602127
    [No Abstract]   [Full Text] [Related]  

  • 12. Concurrent presentation of ocular myasthenia and euthyroid Graves ophthalmopathy: a diagnostic challenge.
    Zouvelou V; Potagas C; Karandreas N; Rentzos M; Papadopoulou M; Zis VP; Vassilopoulos D
    J Clin Neurosci; 2008 Jun; 15(6):719-20. PubMed ID: 18424151
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy.
    Aktaran S; Akarsu E; Erbağci I; Araz M; Okumuş S; Kartal M
    Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of lymphocytic hypophysitis successfully treated with steroid pulse therapy].
    Uyama A; Sasaki M; Ikeda M; Asada M; Teramura K; Tachibana M
    No Shinkei Geka; 2007 Nov; 35(11):1115-9. PubMed ID: 18044230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylprednisolone-induced liver injury: a diagnostic challenge.
    Melamud B; Lurie Y; Goldin E; Levi I; Esayag Y
    Isr Med Assoc J; 2014 Mar; 16(3):180-1. PubMed ID: 24761710
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid-like ophthalmopathy in a euthyroid patient receiving Ipilimumab.
    McElnea E; Ní Mhéalóid A; Moran S; Kelly R; Fulcher T
    Orbit; 2014 Dec; 33(6):424-7. PubMed ID: 25207976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital metastases from neuroendocrine carcinoma, masquerading as graves orbitopathy.
    Sira M; Clauss RP; Maclean C; Rose GE
    Orbit; 2010 Apr; 29(2):94-6. PubMed ID: 20394548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.
    Kvetny J; Puhakka KB; Røhl L
    Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Euthyroid Graves' disease: a case report].
    Hornez N; Morell-Dubois S; Woillez JP; Queyrel V; Charlanne H; Launay D; Lambert M; Hachulla E; Wemeau JL; Hatron PY
    Rev Med Interne; 2009 Nov; 30(11):988-90. PubMed ID: 19299047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.
    Eckstein AK; Lösch C; Glowacka D; Schott M; Mann K; Esser J; Morgenthaler NG
    Br J Ophthalmol; 2009 Aug; 93(8):1052-6. PubMed ID: 19221109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.